Meeting
2023 ASCO Annual Meeting
Gene expression profiling of paired primary breast cancers and brain metastases to identify brain metastases-specific biological changes.
Authors
Gaia Griguolo
Department of Surgery, Oncology and Gastroenterology, University of Padua, and Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
Gaia Griguolo , Maria Vittoria Dieci , Susan Fineberg , Claudia Pinato , Michele Bottosso , Luc Bauchet , Federica Miglietta , Jack Jacob , Giovanni Zarrilli , Valerie Rigau , Maria Cristina Guarascio , Francesca Zanconato , Francesca Schiavi , Matteo Fassan , William Jacot , Stefano Piccolo , Amelie Darlix , Valentina Guarneri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1032)
DOI
10.1200/JCO.2023.41.16_suppl.1032
Abstract #
1032
Poster Bd #
253
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from triple negative breast cancer or HER2+ breast cancer.
First Author: Shipra Gandhi
Poster
2019 ASCO Annual Meeting
NSABP B-41, a randomized neoadjuvant trial: Genes and signatures associated with pathologic complete response (pCR).
First Author: Sandra M. Swain
Poster
2017 ASCO Annual Meeting
Association of molecular subtype, proliferation, and immune genes with efficacy of carboplatin versus gemcitabine addition to taxane-based, anthracycline-free neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Results of the randomized WSG ADAPT-TN trial.
First Author: Oleg Gluz
First Author: Emily Oldham Jenkins